The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) trial 9 demonstrated no survival benefits with a rhythm-control over rate-control strategy. The need for continued ...

Fresh research details a method than can detect congestive heart failure (CHF) using smartwatch ECG data with an impressive ...

The global atrial fibrillation drugs market size was valued at USD 24.59 billion in 2024 and is projected to reach from USD ...

AFib causes an irregular heart rate that can make your heart feel as if it is fluttering or skipping beats. Panic attacks, on ...

researchers conducted an economic analysis on a clinical trial called RATE-AF to look at the differences between two widely ...

A recent Brazilian study published in Nature Cardiovascular Research has highlighted promising pathways for preventing and ...

A team of physicists has developed a groundbreaking method for detecting congestive heart failure with greater ease and precision than previously thought possible. This multidisciplinary study, ...

Sarasota Memorial Hospital has earned the #1 spot among the world's WATCHMAN providers protecting people with atrial ...

Most people aren’t aware of the symptoms, especially if they’re otherwise healthy, because they don’t know that AFib can affect anyone!

Cardiovascular Services The Heart Center at St. Mark’s offers a variety of services for people with heart conditions. The ...

Background Differences in the clinical outcomes and level of risk among Asian versus non-Asian patients with atrial ...

A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with atrial fibrillation and heart failure.